遺傳基因放大技術的全球市場:現狀分析與預測(2022年～2028年)

全球遺傳基因放大技術的市場規模，預計2022年～2028年的預測期間內記錄約7％的年複合成長率。

對遺傳基因放大技術的需求增加，起因於遺傳基因檢驗，分子診斷，及基因學領域的研究開發的必要性高漲。還有各種遺傳基因放大法為基礎的診斷試驗的開拓，及新且先進性的產品簡介，個人化醫療的接收前進，作為市場成長的要素也。再加上政府的法規，序列成本低，研究領域的活性化預計支援成長。可是，有關這些技術的成本高，及基因譯解相關認識低等市場阻礙因素，妨礙市場成長。

本報告提供全球遺傳基因放大技術市場相關調查分析，市場概要，各市場區隔、各地區的市場分析，市場成長的影響因素，市場趨勢，競爭情形，主要企業簡介等彙整資訊。

目錄

第1章 市場簡介

第2章 調查手法與前提

第3章 市場概要

第4章 摘要整理

第5章 COVID-19對遺傳基因放大技術市場的影響

第6章 全球遺傳基因放大技術的市場收益(2020年～2028年)

第7章 市場洞察:各技術

• PCR為基礎的放大
• 複數的位移放大
• 等溫DNA放大
• 其他

第8章 市場洞察:各用途

• 全基因放大
• EXOME定序
• SNP基因型鑑定陣列
• 陣列CGH
• 雜合反應
• 其他

第9章 市場洞察:各終端用戶

• 醫院、診療所
• 製藥及生物科技企業
• 學術研究機關
• 其他

第10章 市場洞察:各地區

• 北美
  • 美國
  • 加拿大
  • 其他北美
• 歐洲
  • 德國
  • 法國
  • 英國
  • 西班牙
  • 義大利
  • 其他歐洲
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 其他亞太地區
• 全球其他地區

第11章 遺傳基因放大技術的市場動態

• 推動市場要素
• 市場課題
• 影響分析

第12章 遺傳基因放大技術的市場機會

第13章 遺傳基因放大技術的市場趨勢洞察

第14章 需求與供給分析

• 需求分析
• 供給分析

第15章 價值鏈分析

第16章 策略性洞察能力

第17章 競爭模式

• 競爭情形
  • 波特的五力分析

第18章 公司概要

• Qiagen NV
• New England Biolabs
• Illumina, Inc.
• Bio-Rad Laboratories, Inc.
• BGI Genomics Co Ltd
• Oxford Nanopore Technologies PLC
• PerkinElmer, Inc.
• Becton Dickinson and Co
• Bayer AG
• Agilent Technologies Inc

第19章 免責聲明

The gene amplification technologies market is expected to register a CAGR of approx. 7% over the period of 2022-2028. Gene amplification technology is a critical component of genomics that is widely used in diagnostics. For various studies, it assists in increasing the number of copies of a gene. Gene amplification is frequently carried out using dendritic polymers, transcription-mediated amplification, polymerase chain reaction to ligase chain reaction, and other methods. The main purpose of gene amplification technology is to compare the gene of the study sample with the genes of other germline or somatic cells. The growing demand for gene amplification technologies can be attributed to the expanding need for research and development in the fields of genetic testing, molecular diagnostics, and genomics which boosts the adoption of organic growth strategies among key industry players around the globe. For instance, in august 2022, QIAGEN launched new solutions that significantly accelerate DNA variant detection and RNA sequencing of low-input samples. QIAseq Targeted DNA Pro Panels are based on improved chemistry that halves to six hours the time researchers need for library preparation of DNA samples. Owing to the glaring statistics the increasing development of numerous diagnostic tests based on various gene amplification methods led to the growing demand for gene amplification technologies and would contribute to the growth of the market in the forthcoming period as well. In addition, the introduction of novel and advanced products and the growing acceptance of personalized medicine are likely to aid the market growth. Furthermore, the gene amplification technologies market is anticipated to grow on account of government regulations, decreasing sequencing costs together boosting the research field. However, some of the restraints in the market including the high costs of these technologies and limited awareness about genome sequencing are impeding the growth of this market all over the world.

Based on the technology, the gene amplification technologies market is segmented into PCR-based amplification, multiple displacement amplification, isothermal DNA amplification, and others. The PCR-based amplification segment accounted for a significant market share, and it is estimated that it will grow rapidly during the projected timeframe. PCR technology is widely used in a variety of end-use applications. Furthermore, the widespread use of PCR for COVID-19 detection has resulted in significant revenue generation by this technology.

Based on the application, the market is fragmented into whole genome amplification, exome sequencing, SNP genotyping arrays, array CGH, hybridization, and others. The hybridization segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. In the hybridization process, several multiplication technologies are increasingly being used.

Based on the end-users, the market is fragmented into hospitals & clinics, pharmaceutical & biotechnology companies, academic & research institutes, and others. The pharmaceutical & biotechnology companies segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. These businesses are concentrating on the creation of molecular diagnostic tests based on amplification techniques, which is promoting market expansion. Additionally, the market is expected to grow due to the expansion of applications in areas such as drug discovery, food quality control, bioremediation, and others.

For a better understanding of the market adoption of gene amplification technologies, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, U.K., and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the gene amplification technologies industry owing to the presence of various genetic research programs in the region, as well as strong research and a commercial base for gene multiplication products, and growing funding by numerous government organizations in medical research and its infrastructure, which are the major factors contributing to the growth of the market.

Some of the major players operating in Qiagen NV; New England Biolabs; Illumina, Inc.; Bio-Rad Laboratories, Inc.; BGI Genomics Co Ltd; Oxford Nanopore Technologies PLC; PerkinElmer, Inc.; Becton Dickinson and Co; Bayer AG; AND Agilent Technologies Inc among others. Several M&A's along with partnerships have been undertaken by these players.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Main Objective
• 1.3. Stakeholders
• 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Gene Amplification Technologies Market
• 2.2. Research Methodology of the Gene Amplification Technologies Market
• 2.4. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE GENE AMPLIFICATION TECHNOLOGIES MARKET

6 GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY TECHNOLOGY

• 7.1. PCR-based Amplification
• 7.2. Multiple Displacement Amplification
• 7.3. Isothermal DNA Amplification
• 7.4. Others

8 MARKET INSIGHTS BY APPLICATION

• 8.1. Whole Genome Amplification
• 8.2. Exome Sequencing
• 8.3. SNP Genotyping Arrays
• 8.4. Array CGH
• 8.5. Hybridization
• 8.6. Others

9 MARKET INSIGHTS BY END-USERS

• 9.1. Hospitals & Clinics
• 9.2. Pharmaceutical & Biotechnology Companies
• 9.3. Academic & Research Institutes
• 9.4. Others

10 MARKET INSIGHTS BY REGION

• 10.1 NORTH AMERICA GENE AMPLIFICATION TECHNOLOGIES MARKET
  • 10.1.1 United States
  • 10.1.2 Canada
  • 10.1.3 Rest of North America
• 10.2 EUROPE GENE AMPLIFICATION TECHNOLOGIES MARKET
  • 10.2.1 Germany
  • 10.2.2 France
  • 10.2.3 United Kingdom
  • 10.2.4 Spain
  • 10.2.5 Italy
  • 10.2.6 Rest of Europe
• 10.3 ASIA PACIFIC GENE AMPLIFICATION TECHNOLOGIES MARKET
  • 10.3.1 China
  • 10.3.2 Japan
  • 10.3.3 India
  • 10.3.4 Australia
  • 10.3.5 Rest of Asia Pacific
• 10.4 REST OF THE WORLD GENE AMPLIFICATION TECHNOLOGIES MARKET

11 GENE AMPLIFICATION TECHNOLOGIES MARKET DYNAMICS

• 11.1 Market Drivers
• 11.2 Market Challenges
• 11.3 Impact Analysis

12 GENE AMPLIFICATION TECHNOLOGIES MARKET OPPORTUNITIES

13 GENE AMPLIFICATION TECHNOLOGIES MARKET TRENDS & INSIGHTS

14 DEMAND AND SUPPLY SIDE ANALYSIS

• 14.1 Demand Side Analysis
• 14.2 Supply Side Analysis

15 VALUE CHAIN ANALYSIS

16 STRATEGIC INSIGHTS

17 COMPETITIVE SCENARIO

• 17.1. Competitive Landscape
  • 17.1.1 Porter's Five forces analysis

18 COMPANY PROFILED

• 18.1. Qiagen NV
• 18.2. New England Biolabs
• 18.3. Illumina, Inc.
• 18.4. Bio-Rad Laboratories, Inc.
• 18.5. BGI Genomics Co Ltd
• 18.6. Oxford Nanopore Technologies PLC
• 18.7. PerkinElmer, Inc.
• 18.8. Becton Dickinson and Co
• 18.9. Bayer AG
• 18.10. Agilent Technologies Inc

19 DISCLAIMER